VION PHARMACEUTICALS INC
10-Q, EX-27, 2000-11-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: VION PHARMACEUTICALS INC, 10-Q, 2000-11-13
Next: CET ENVIRONMENTAL SERVICES INC, 10-Q, 2000-11-13



<TABLE> <S> <C>

<ARTICLE>                      5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S FINANCIAL STATEMENTS FOR THE PERIOD ENDED DECEMBER 31, 1999 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                                                   <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                                           DEC-31-2000
<PERIOD-START>                                              JAN-01-2000
<PERIOD-END>                                                SEP-30-2000
<CASH>                                                       13,089,583
<SECURITIES>                                                 14,523,439
<RECEIVABLES>                                                   327,860
<ALLOWANCES>                                                          0
<INVENTORY>                                                           0
<CURRENT-ASSETS>                                             27,988,779
<PP&E>                                                          659,181
<DEPRECIATION>                                                        0
<TOTAL-ASSETS>                                               29,115,652
<CURRENT-LIABILITIES>                                         1,285,970
<BONDS>                                                               0
                                                 0
                                                          42
<COMMON>                                                        261,123
<OTHER-SE>                                                   27,568,517
<TOTAL-LIABILITY-AND-EQUITY>                                 27,829,682
<SALES>                                                               0
<TOTAL-REVENUES>                                                786,805
<CGS>                                                                 0
<TOTAL-COSTS>                                                         0
<OTHER-EXPENSES>                                             10,915,210
<LOSS-PROVISION>                                                      0
<INTEREST-EXPENSE>                                                9,362
<INCOME-PRETAX>                                              (9,133,879)
<INCOME-TAX>                                                          0
<INCOME-CONTINUING>                                                   0
<DISCONTINUED>                                                        0
<EXTRAORDINARY>                                                       0
<CHANGES>                                                             0
<NET-INCOME>                                                 (9,133,879)
<EPS-BASIC>                                                       (0.42)
<EPS-DILUTED>                                                     (0.42)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission